Skip to main content
. 2014 Aug;88(15):8407–8420. doi: 10.1128/JVI.01237-14

TABLE 1.

Characteristics of subtype B R5 SHIVSF162P3N-, subtype C SHIVC109P3-, and SHIVC109P3N-infected macaques with SHIVEa

Virus Animal Age (yr) Mamu alleleb
Route Dose (TCID50)c Time to AIDS (wk) Coreceptor switch (X4 V3 sequence)e SHIV binding antibody
A*01 B*08 B*17
SHIVSF162P3N DE86 5.69 I.v. 3,000 12d Yes (GHI insertion) Transient
T799 9.90 I.v. 3,000 224 Yes (S11 K/R) High, persistent
DG07 6.71 I.r. 10,000 7d No Transient
DG08 6.98 I.r. 10,000 20d Yes (HI/HR insertion, ΔATGD) Not detected
DN57 5.84 I.r. 10,000 30d No Weak, persistent
ET94 6.50 I.r. 10,000 39 Yes (HR insertion) Weak, persistent
DG17 8.55 I.vg. 1,000 22d No Not detected
SHIVC109P3 GC98 7.21 + I.r. 5,000 20d No Not detected
SHIVC109P3N FI08 7.62 I.r. 5,000 10d Yes (ΔIGDI) Not detected
a

The age at the time of virus challenge, status of restrictive MHC class I genotype, inoculation route, dose of the virus inoculum and time to AIDS of the SHIVE macaques are shown. Presence of coreceptor switch, V3 sequence dictating the switch to CXCR4 usage, and status of SHIV binding antibody in the animals are also indicated.

b

−, absent; +, present.

c

TCID50, 50% tissue culture infectious dose.

d

Rapid progressor.

e

Δ denotes deletion in the V3 loop.